HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 6702 | 8290 | 80.8% | |
| HF 4 | 2011 | 7383 | 9201 | 80.2% | |
| HF 4 | 2012 | 8136 | 10012 | 81.3% | |
| HF 4 | 2013 | 8768 | 10337 | 84.8% | |
| HF004W | 2014 | 4777 | 5241 | 91.1% | |
| HF004 | 2015 | 6123 | 6749 | 90.7% |
